Acta Scientific PAEDIATRICS (ISSN: 2581-883X)

Review Article Volume 6 Issue 9

Diagnosis and Management of Attention Deficit Hyperactivity Disorder (ADHD) in Paediatric Patients

Edwin Dias1*, Sarah Rafiq2 and Saipriya Pothireddy3

1Professor and Head, Department of Paediatrics, Srinivas Institute of Medical Sciences and Research Centre, Mangalore, Karnataka State, India
2Final Year, Pharm D, Srinivas College of Pharmacy, Valachil, Mangalore, Karnataka State, India
3First Year, Paediatrics Resident, Srinivas Institute of Medical Sciences and Research Centre, Mangalore, Karnataka State, India

*Corresponding Authorship: Edwin Dias, Professor and Head, Department of Paediatrics, Srinivas Institute of Medical Sciences and Research Centre, Mangalore, Karnataka State, India.

Received: September 14, 2022; Published: September 29, 2023


Purpose: The neurodevelopmental disorder Attention-Deficit/Hyperactivity Disorder (ADHD) is prevalent in children all over the world. With an emphasis on clinical assessment, differential diagnosis, and comorbidities connected to the disorder, this review article offers an overview of the diagnosis and therapy of ADHD in kids. It investigates the difficulties of overdiagnosis and underdiagnosis, stigma and societal effects, healthcare access, and long-term results for people with ADHD.

Design/Methodology/Approach: This study is review-based. In this review, the researcher makes an effort to provide a brief, pragmatic suggestion by using the comprehensive literature. Throughout the review, the researcher makes extensive use of deductive logic reasoning. The scientific assessment would employ techniques like extensive archive investigation followed by a thorough evaluation.

Findings/Result: One of the most prevalent neurobehavioral disorders in children and young adults is ADHD. This review presents a summary of recent research on issues related to the signs and treatments of ADHD. There are methods for individualized neurofeedback and pharmaceutical therapy presented. The study's primary objective is to conduct a complete analysis of the array of research now available about ADHD and to provide medical practitioners with knowledge about its diagnosis, evaluation, and therapy.

Paper Type: Review Paper.

Keywords: Attention Deficit; Hyperactive; Diagnosis; Symptoms; Treatment


  1. Calvin N., et al. “Effect of Omega-3 as an Add-on Therapy in Reducing Inattention Symptoms in Children and Adolescents with Attention Deficit-Hyperactivity Disorder: An Evidence-Based Case Report”.
  2. Thapar A., et al. “Practitioner review: what have we learnt about the causes of ADHD?”. Journal of Child Psychology and Psychiatry1 (2013): 3-16.
  3. Hyman SE. “The diagnosis of mental disorders: the problem of reification”. Annual review of Clinical Psychology 6 (2010): 155-179.
  4. Dias TG., et al. “Developments and challenges in the diagnosis and treatment of ADHD”. Brazilian Journal of Psychiatry 35 (2013): S40-50.
  5. Mahone EM and Denckla MB. “Attention-deficit/hyperactivity disorder: a historical neuropsychological perspective”. Journal of the International Neuropsychological Society9-10 (2017): 916-929.
  6. Kendall J. “Sibling accounts of attention deficit hyperactivity disorder (ADHD)”. Family process1 (1999): 117-136.
  7. Diamond A. “Attention-deficit disorder (attention-deficit/hyperactivity disorder without hyperactivity): A neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity)”. Development and Psychopathology3 (2005): 807-825.
  8. Gibbins C., et al. “ADHD-hyperactive/impulsive subtype in adults”. Mental Illness1 (2010): 41-45.
  9. Peasgood T., et al. “The impact of ADHD on the health and well-being of ADHD children and their siblings”. European Child and Adolescent Psychiatry 25 (2016): 1217-1231.
  10. Tripp G., et al. “DSM-IV and ICD-10: a comparison of the correlates of ADHD and hyperkinetic disorder”. Journal of the American Academy of Child and Adolescent Psychiatry 2 (1999): 156-164.
  11. Abuse S and Administration MH. “DSM-5 Changes: Implications for Child Serious Emotional Disturbance”.
  12. Keen D and Hadjikoumi I. “Attention deficit hyperactivity disorder in children and adolescents”. BMJ Clinical Evidence (2015).
  13. Kendall T., et al. “Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance”. Bmj (2008): 337.
  14. Cabral MD., et al. “Attention-deficit/hyperactivity disorder: diagnostic criteria, epidemiology, risk factors and evaluation in youth”. Translational Pediatrics 1 (2020): S104.
  15. Bélanger SA., et al. “ADHD in children and youth: Part 1—Etiology, diagnosis, and comorbidity”. Paediatrics and Child Health 7 (2018): 447-453.
  16. Drechsler R., et al. “ADHD: Current concepts and treatments in children and adolescents”. Neuropediatrics 5 (2020): 315-335.
  17. Shrestha M., et al. “Non-pharmacologic management of attention-deficit/hyperactivity disorder in children and adolescents: a review”. Translational Pediatrics1 (2020): S114.
  18. Pfiffner LJ and Haack LM. “Behaviour management for school-aged children with ADHD”. Child and Adolescent Psychiatric Clinics4 (2014): 731-746.
  19. Kolar D., et al. “Treatment of adults with attention-deficit/hyperactivity disorder”. Neuropsychiatric Disease and Treatment1 (2008): 107-121.
  20. Adesman AR. “The diagnosis and management of attention-deficit/hyperactivity disorder in pediatric patients”. Primary Care Companion to the Journal of Clinical Psychiatry2 (2001): 66.
  21. Murray DW., et al. “Prevalence and characteristics of school services for high school students with attention-deficit/hyperactivity disorder”. School Mental Health 6 (2014): 264-278.
  22. Srinath S., et al. “Clinical practice guidelines for assessment of children and adolescents”. Indian Journal of Psychiatry 61 (2019): 158.
  23. Epstein JN., et al. “Changes in the definition of ADHD in DSM-5: subtle but important”. Neuropsychiatry 5 (2013): 455.
  24. Alhossein A., et al. “Psychometric Properties of ADHD Rating Scale—5 for Children and Adolescents in Sudan—School Version”. Frontiers in Psychology 13 (2022): 883578.
  25. Kohli A., et al. “Specific learning disabilities: Issues that remain unanswered”. Indian Journal of Psychological Medicine5 (2018): 399-405.
  26. Wilens TE and Spencer TJ. “Understanding attention-deficit/hyperactivity disorder from childhood to adulthood”. Postgraduate Medicine5 (2010): 97-109.
  27. Chiu A., et al. “Anxiety disorders among children and adolescents”. Focus1 (2016): 26-33.
  28. Dougnon G and Matsui H. “Modelling autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) using mice and zebrafish”. International Journal of Molecular Sciences14 (2022): 7550.
  29. Ghosh S and Sinha M. “ADHD, ODD, and CD: Do they belong to a common psychopathological spectrum? A case series”. Case Reports in Psychiatry (2012).
  30. Oluwabusi OO., et al. “Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options”. World Journal of Clinical Pediatrics1 (2011): 128.
  31. Zwi M., et al. “Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years”. Cochrane Database of Systematic Reviews 12 (2011).
  32. Tresco KE., et al. “Psychosocial interventions to improve the school performance of students with attention-deficit/hyperactivity disorder”. Mind and Brain: The Journal of Psychiatry2 (2010): 69.
  33. Budur K., et al. “Non-stimulant treatment for attention deficit hyperactivity disorder”. Psychiatry (Edgmont)7 (2005): 44.
  34. Advokat C and Scheithauer M. “Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers”. Frontiers in Neuroscience 7 (2013): 82.
  35. Faraone SV. “The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities”. Neuroscience and Biobehavioral Reviews 87 (2018): 255-270.
  36. Garnock-Jones KP and Keating GM. “Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents”. Pediatric Drugs 11 (2009): 203-226.
  37. Ogundele MO and Ayyash HF. “ADHD in children and adolescents: Review of current practice of non-pharmacological and behavioural management”. AIMS Public Health1 (2023): 35.
  38. Haugan AL., et al. “Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial”. BMC Psychiatry1 (2022): 375.
  39. Nigg JT and Holton K. “Restriction and elimination diets in ADHD treatment”. Child and Adolescent Psychiatric Clinics4 (2014): 937-953.
  40. Mulqueen J. “Nutritional supplements for the treatment of attention-deficit hyperactivity disorder”. Child and Adolescent Psychiatric Clinics of North America 23 (2014): 883-897.
  41. Enriquez-Geppert S., et al. “Neurofeedback as a treatment intervention in ADHD: current evidence and practice”. Current Psychiatry Reports 21 (2019): 1-7.
  42. Lee CS., et al. “The effectiveness of mindfulness-based intervention in attention on individuals with ADHD: A systematic review”. Hong Kong Journal of Occupational Therapy 30.1 (2017): 33-41.
  43. Kazda L., et al. “Overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic scoping review”. JAMA Network Open4 (2021): e215335.
  44. Mueller AK., et al. “Stigma in attention deficit hyperactivity disorder”. Attention Deficit Hyperactivity Disorder 3 (2020): 101-114.
  45. Ramsay JR. “Health care systems issues and disparities in ADHD care for African American adults”. The Journal of Clinical Psychiatry12 (2014): 27702.
  46. Nigg JT., et al. “Development of ADHD: Etiology, heterogeneity, and early life course”. Annual Review of Developmental Psychology 2 (2020): 559-583.


Citation: Edwin Dias., et al. “Diagnosis and Management of Attention Deficit Hyperactivity Disorder (ADHD) in Paediatric Patients". Acta Scientific Paediatrics 6.9 (2023): 35-44.


Copyright: © 2023 Edwin Dias., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In

News and Events

Contact US